PKI-402

CAS No. 1173204-81-3

PKI-402 ( PKI 402;PKI402 )

Catalog No. M10583 CAS No. 1173204-81-3

A potent dual PI3K/mTOR inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 110 In Stock
10MG 177 In Stock
25MG 357 In Stock
50MG 530 In Stock
100MG 759 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PKI-402
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent dual PI3K/mTOR inhibitor.
  • Description
    A potent dual PI3K/mTOR inhibitor with IC50 of 1/7/16/14/1.7 nM for PI3Kα/β/γ/δ/mTOR respectively; shows excellent suppression of Akt T308 phosphorylation (IC50=5 nM), and excellent inhibition of cell proliferation in several human cancer cell lines; shows excellent in vivo efficacy in various human cancer xenografts, good physical properties and PK parameters.
  • Synonyms
    PKI 402;PKI402
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1173204-81-3
  • Formula Weight
    570.65
  • Molecular Formula
    C29H34N10O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: < 1 mg/mL
  • SMILES
    O=C(NC1=CC=C(C(N2CCN(C)CC2)=O)C=C1)NC3=CC=C(C4=NC(N5CCOCC5)=C(N=NN6CC)C6=N4)C=C3
  • Chemical Name
    Urea, N-[4-[3-ethyl-7-(4-morpholinyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]phenyl]-N'-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dehnhardt CM, et al. J Med Chem. 2010 Jan 28;53(2):798-810.
2. Mallon R, et al. Mol Cancer Ther. 2010 Apr;9(4):976-84.
molnova catalog
related products
  • Dactolisib

    A potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively.

  • CYH33 methanesulfona...

    CYH33 (CYH-33) is a novel potent, PI3Kα-selective inhibitor with IC50 of 5.9 nM/598 nM/ 78.7 nM/225 nM aginst class I PI3K isoform α/β/δ/γ, respectively.

  • AS-041164

    AS-041164 is a selective and orally active PI3Kγ isoform inhibitor(IC50 of 70 nM), and shows less activity against PI3Kα, PI3Kβ, and PI3Kδ (IC50s of 240 nM, 1.45 μM, and 1.70 μM, respectively).